Nan Xu

机构：Lithuanian Sports University, Henan University, Liaoning University of Traditional Chinese Medicine, Second Affiliated Hospital of Xi'an Jiaotong University, National Institutes for Food and Drug Control, First Affiliated Hospital of Bengbu Medical College · ORCID：0000-0003-1212-7773

发表论文 185 篇 · 总被引 3180 次 · h-index 31

代表论文

• Exploring the mechanism of triptolide inhibiting the motility of fibroblast-like synoviocytes in rheumatoid arthritis via RhoA/Rho-associated kinase axis, based on network pharmacology, molecular docking and molecular dynamics simulations (2025 · Frontiers in Pharmacology · 被引 11)
• 177Lu-Dotatate versus high-dose long-acting octreotide for the treatment of patients with advanced, grade 1-2, well-differentiated gastroenteropancreatic neuroendocrine tumours (XT-XTR008-3-01): an open-label, randomised, phase III trial (2025 · Annals of Oncology · 被引 5)
• From innate power to intelligent design: The evolution of NK cell-based cancer immunotherapy (2025 · Critical Reviews in Oncology/Hematology · 被引 4)
• NEV battery recycling innovation strategy considering pro-social behavior from the game theory perspective (2025 · Scientific Reports · 被引 4)
• Immune status assessment based on plasma proteomics with meta graph convolutional networks (2025 · BMC Genomics · 被引 3)
• Production of virus-like particles of FMDV by 3C protease cleaving precursor polyprotein P1 in vitro (2024 · Applied Microbiology and Biotechnology · 被引 3)